Kshitis Chandra Baral
Overview
Explore the profile of Kshitis Chandra Baral including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baral K, Lee S, Song J, Jeong S, Han H
Pharmaceutics
. 2023 Dec;
15(12).
PMID: 38140061
MT-102 is a new anti-inflammatory agent derived from and . Its therapeutic potential is hindered by low aqueous solubility, impacting its in vivo efficacy. Therefore, this study aimed to develop...
2.
Bajracharya R, Baral K, Lee S, Song J, Han H
Int J Nanomedicine
. 2023 Dec;
18:7257-7266.
PMID: 38076733
Purpose: Oral administration, although convenient and preferred for treating colorectal cancer (CRC), faces challenges due to limited CRC-related intestinal positioning and a dense mucus barrier. In the present study, a...
3.
Song J, Baral K, Kim G, Park J, Seo S, Kim D, et al.
Drug Deliv
. 2023 Mar;
30(1):2183816.
PMID: 36880122
Pharmaceutical application of therapeutic proteins has been continuously expanded for the treatment of various diseases. Efficient and reliable bioanalytical methods are essential to expedite the identification and successful clinical development...
4.
Baral K, Bajracharya R, Lee S, Han H
Int J Nanomedicine
. 2021 Nov;
16:7535-7556.
PMID: 34795482
Probiotics have demonstrated their high potential to treat and/or prevent various diseases including neurodegenerative disorders, cancers, cardiovascular diseases, and inflammatory diseases. Probiotics are also effective against multidrug-resistant pathogens and help...
5.
Baral K, Song J, Lee S, Bajracharya R, Sreenivasulu G, Kim M, et al.
Pharmaceutics
. 2021 Aug;
13(8).
PMID: 34452103
AC1497 is an effective dual inhibitor of malate dehydrogenase 1 and 2 targeting cancer metabolism. However, its poor aqueous solubility results in low bioavailability, limiting its clinical development. This study...